SUTRO
Summary of public USPTO data
- Owner
- Sutro Biopharma, Inc.
- Status
- Live/Registered
- Serial number
- 98694731
- Registration number
- 8357229
- Filing date
- 2024-08-12
- Registration date
- 2026-07-21
- International classes
- 5, 40, 42
Goods and services
Class 5
- Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways
- Pharmaceutical and biological preparations for use in oncology
- Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer
- Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, dual conjugates, cytokines, bispecific antibodies, and engineered antibodies for destroying tumor cells and stimulating immune response
- Vaccines
- Bacterial lysate preparations and bacterial extract preparations, for use in the cell free production of therapeutic proteins and peptides for medical use
Class 40
- Custom manufacturing of pharmaceuticals and therapeutic agents for medical use
- Custom manufacturing of bacterial lysate preparations and bacterial extract preparations.
Class 42
- Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, dual conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology
- Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology
- Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases.